Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar BLAYNE100 (51.91) Submitted: 11/16/2009 8:46:42 PM : Outperform Start Price: $53.76 CVD Score: -32.51

Strong Sector for 2010

Featured Broker Partners


Advertisement